Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Κ-opioid receptor - an overview | ScienceDirect Topics
Opioids and Their Complicated Receptor Complexes | Neuropsychopharmacology
Molecular mechanisms of opioid receptor-dependent signaling and behavior. - Abstract - Europe PMC
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
κ-opioid receptor - Wikipedia
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect
Samenvatting Medical Pharmacology and Therapeutics - Samenvatting farma - Aantekeningen farmacologie - Studeersnel
Opioids and Their Complicated Receptor Complexes | Neuropsychopharmacology
Opioid Receptor | kappa, mu Opioid Receptor
Workshop voor apothekers en huisartsen
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Development of κ opioid receptor antagonists. | Semantic Scholar
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
κ receptor | Opioid receptors | IUPHAR/BPS Guide to PHARMACOLOGY
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Κ-opioid receptor - an overview | ScienceDirect Topics
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists